explore -WSS

explore

author：comprehensive 2025-09-06 04:37:40 - browse：67769

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Neuroscience’s long legacy of racism

focus

WSS

David Sabatini, ex

Addiction doctors spar with methadone clinics over legislation

Virtual Event: March of the Biosimilars

Scientists successfully use ultrasound imaging to map brain activity

Plastic surgeons increase patient psychiatric screenings

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

entertainment

explore

entertainment

The high cost of giving birth even with insurance

Physicians and social media: If you see something, say something?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Baby aspirin cuts fat buildup in liver disease patients, in small study

At least 13 dead in Texas as scorching temps continue

Creating egg and sperm cells from stem cells raises ethical issues

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Intermittent fasting comes with a heart risk? Not so fast

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Positive childhood experiences can help future health

explore

5 to watch: Tech startups trying to solve health care's staffing crisis

Stop the failed accountable care organization experiment

Insmed lung disease drug hits target in key Phase 3 trial

Virtual Event: March of the Biosimilars

5 to watch: Tech startups trying to solve health care's staffing crisis

Startling documents reveal new facets of Sacklers' opioid empire

focus

focus

explore

focus